MARKET

AIM

AIM

Aim Immunotech
AMEX
0.1380
-0.0190
-12.10%
After Hours: 0.1387 +0.0007 +0.51% 19:34 11/10 EST
OPEN
0.1599
PREV CLOSE
0.1570
HIGH
0.1640
LOW
0.1200
VOLUME
1.85M
TURNOVER
--
52 WEEK HIGH
1.820
52 WEEK LOW
0.1200
MARKET CAP
5.51M
P/E (TTM)
-0.0351
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AIM last week (1102-1106)?
Weekly Report · 1d ago
AIM ImmunoTech Inc. Highlights Ampligen Opportunity and 2027 Milestones
NASDAQ · 4d ago
AIM ImmunoTech Furnishes Corporate Presentation on Ampligen Opportunity
TipRanks · 5d ago
AIM ImmunoTech Says Phase 2 DURIPANC Topline Results Expected In Q1 2027, With Additional Clinical And Immune-Response Analyses Anticipated In Q3 2027
Benzinga · 5d ago
Weekly Report: what happened at AIM last week (1026-1030)?
Weekly Report · 11/02 09:50
'Congo Ebola Cases Top 10,000 as Violence Hits Health Workers' - Bloomberg
Benzinga · 10/27 12:39
Weekly Report: what happened at AIM last week (1019-1023)?
Weekly Report · 10/26 09:50
Weekly Report: what happened at AIM last week (1012-1016)?
Weekly Report · 10/19 09:50
More
About AIM
AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company's flagship product Ampligen is a double-stranded ribonucleic acid (dsRNA) molecule being developed for globally important cancers, viral diseases and disorders of the immune system. The Alferon N Injection (Interferon alfa) is an injectable formulation of natural alpha interferon, which is approved for sale in the United States and Argentina for the intralesional treatment of refractory or recurring external genital warts in patients 18 years of age or older. It is also approved in Argentina for the treatment of refractory patients that failed or were intolerant to treatment with recombinant interferons. Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe chronic fatigue syndrome (CFS).

Webull offers AIM ImmunoTech Inc stock information, including AMEX: AIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AIM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AIM stock methods without spending real money on the virtual paper trading platform.